SCHEMBL9005655

SCHEMBL9005655

O=C(O)COc1cccc2c1CCC(CCC=NOC(c1ccccc1)c1ccccc1)C2

nearest known ligand 0.85

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 18/20 0.85
TBXAS1 P24557 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9005540 1.00 PTGIR (0.85) PTGIRTBXAS1
SCHEMBL9005666 0.92 PTGIR (1.00) PTGIRTBXAS1
SCHEMBL9005672 0.92 PTGIR (1.00) PTGIRTBXAS1
SCHEMBL9005753 0.85 PTGIR (0.77) PTGIRTBXAS1
SCHEMBL9005740 0.85 PTGIR (0.77) PTGIRTBXAS1
SCHEMBL9005816 0.84 PTGIR (0.72) PTGIRTBXAS1
SCHEMBL9005776 0.84 PTGIR (0.72) PTGIRTBXAS1
SCHEMBL9005711 0.83 PTGIR (0.69) PTGIR
SCHEMBL9005624 0.82 PTGIR (1.00) PTGIRTBXAS1
SCHEMBL9005620 0.82 PTGIR (1.00) PTGIRTBXAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0578847-B1 Fused benzeneoxyacetic acid derivatives and their use as PG12 antagonists ONO PHARMACEUTICAL CO (JP) 1996-10-09 EP claimed
EP-0578847-A1 Fused benzeneoxyacetic acid derivatives and their use as PG12 antagonists ONO PHARMACEUTICAL CO., LTD. (JP) 1994-01-19 EP claimed
EP-0578847-B1 Fused benzeneoxyacetic acid derivatives and their use as PG12 antagonists ONO PHARMACEUTICAL CO (JP) 1996-10-09 EP disclosed
US-5461045-A Treating thrombosis, arteriosclerosis, ischemic heart diseases, gastric ulcer and hypertension ONO PHARMACEUTICAL CO., LTD. (JP) 1995-10-24 US disclosed
EP-0578847-A1 Fused benzeneoxyacetic acid derivatives and their use as PG12 antagonists ONO PHARMACEUTICAL CO., LTD. (JP) 1994-01-19 EP disclosed